Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Guidance - March 2019

The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of March 2019. This month there is one guideline that impacts upon primary care.

The Delirium: prevention, diagnosis and management guideline has been updated. It covers diagnosing and treating delirium in people aged 18 and over in hospital and in long-term residential care or a nursing home. It also covers identifying people at risk of developing delirium in these settings and preventing onset. It aims to improve diagnosis of delirium and reduce hospital stays and complications. The update removed the recommendation to use of olanzapine for the treatment of delirium in people who are distressed or considered a risk to themselves or others.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - March 2019' on Email Share 'NICE Guidance - March 2019' on Delicious Share 'NICE Guidance - March 2019' on Digg Share 'NICE Guidance - March 2019' on Facebook Share 'NICE Guidance - March 2019' on reddit Share 'NICE Guidance - March 2019' on StumbleUpon Share 'NICE Guidance - March 2019' on Twitter

atomic-wealth

No Comments to “NICE Guidance - March 2019”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer